Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Amifostine thiol is a radioprotective agent and an active metabolite of amifostine (Item No. 14398).1 It is formed from amifostine by plasma membrane-bound alkaline phosphatase. Amifostine thiol scavenges ABTS (Item No. 27317) radicals in a cell-free assay.2 It prevents single- and double-stranded DNA breaks induced by γ-radiation, as well as inhibits γ-radiation-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase (HGPRT) locus in V79-B310H lung fibroblast cells when used at a concentration of 4 mM.3,4,5 Amifostine thiol also reduces cis-DDP-induced mutations at the HGPRT locus in V79-B310H cells.6 It increases survival, reduces the loss of bone marrow progenitor cells, and inhibits decreases in intestinal collagen thickness and crypt and Paneth cell density in mice exposed to total body γ-irradiation when administered at a dose of 500 mg/kg prior to irradiation.7
WARNING This product is not for human or veterinary use.
1. Pharmacokinetic profile of amifostine. Semin. Oncol. 23(4 Suppl 8), 18-22 (1996).
2. Comparative reaction rates of various antioxidants with ABTS radical cation. J. Agric. Food Chem. 57(4), 1156-1161 (2009).
3. The effect of 2-
4. The effect of 2-
5. The radioprotector WR1065 reduces radiation-
6. Protection against cis-
7. Radioprotection in mice following oral administration of WR-